Benchmark dose for cadmium exposure and elevated N-acetyl-β-d-glucosaminidase: a meta-analysis

Cadmium (Cd) is a well-known nephrotoxic contaminant, and N-acetyl-β- d -glucosaminidase (NAG) is considered to be an early and sensitive marker of tubular dysfunction. The link between Cd exposure and NAG level enables us to derive the benchmark dose (BMD) of Cd. Although several reports have already documented urinary Cd (UCd)-NAG relationships and BMD estimations, high heterogeneities arise due to the sub-populations (age, gender, and ethnicity) and BMD methodologies being employed. To clarify the influences that these variables exert, firstly, a random effect meta-analysis was performed in this study to correlate the UCd and NAG based on 92 datasets collected from 30 publications. Later, this established correlation ( Ln ( NAG ) = 0.51 × Ln ( UCd ) + 0.83) was applied to derive the UCd BMD 5 of 1.76 μg/g creatinine and 95 % lower confidence limit of BMD 5 (BMDL 5 ) of 1.67 μg/g creatinine. While the regressions for different age groups and genders differed slightly, it is age and not gender that significantly affects BMD estimations. Ethnic differences may require further investigation given that limited data is currently available. Based on a comprehensive and systematic literature review, this study is a new attempt to quantify the UCd-NAG link and estimate BMD.